Ruixiao Lu

Ruixiao Lu has a diverse work experience spanning multiple companies and roles. Currently, they are the VP and Head of Biostatistics and Statistical Programming at Alumis, a precision medicine company focused on autoimmune diseases. They have also held leadership positions at various organizations such as the Bay Area Biotech-Pharma Statistics Workshop (BBSW) and the American Statistical Association (ASA). In addition, they have co-founded a non-profit organization called DahShu and have worked in the biostatistics field at companies like Quantum Leap Healthcare Collaborative, Exact Sciences, Genomic Health, Novartis, Affymetrix, and Tethys Bioscience, Inc. Throughout their career, Ruixiao has demonstrated their expertise in statistical analysis, team management, and strategic leadership.

Ruixiao Lu obtained a Bachelor's degree in Statistics from Peking University, School of Mathematical Sciences, from 1999 to 2003. They went on to pursue a PhD in Statistics (with an emphasis in Biostatistics) from the University of California, Davis, completing their studies from 2003 to 2007.